Page 47 - Roche Low Code Enablement Application Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche low code enablement application platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Low Code Enablement Application Platform Today - Breaking & Trending Today

Roche To Buy Good Therapeutics Conditionally Active PD-1-regulated IL-2 Program

SOUTH SAN FRANCISCO (dpa-AFX) - Good Therapeutics Wednesday said Roche Holding AG (RHHBY) has agreed to acquire Good Therapeutics' conditionally active PD-1-regulated IL-2 Program.The deal also ....

James Sabry , Roche Holding , Therapeutics Wednesday , Good Therapeutic , Good Therapeutics , Global Head , Pharma Partnering ,

A Local Record Store Needs Your Help! Here's What You Can Do. | Indy 103.3

Vinyl lovers! It's time to come together to help out a store that has been essential to our community. The Record Exchange in Frederick, MD was destroyed by a fire recently. Rather than give up, The Record Exchange family has decided to rebuild. Here's how you can help. ....

Record Exchange , Record Exchange In Frederick , He Record Exchange ,

Roche launches digital PCR system for ultra-rare and emerging diseases

Using the system, the researchers are able to divide DNA and RNA from an already extracted clinical sample into as many as 100,000 microscopic individual reactions - News - PharmaTimes ....

Thomas Schinecker , Drug Administration , Digital Lightcycler System , Roche Diagnostics , Igital Lightcycler System , Genetic Disease , Polymerase Chain Reaction ,

THIRSTDAY! Hang With Roche At Looney's Pub! | ALT 1033

Thirstday hang brings Roche to Looney's Pub and a chance to win $500! ....

Looney Pub In College Park , Flying Dog Brewery , College Park , Flying Dog , Craft Beer , Flying Dog ,

Roche's VENTANA PD-L1 (SP263) test gains CE label expansion as a companion diagnostic to identify non-small cell lung cancer patients eligible for Tecentriq

/PRNewswire/ Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced CE label expansion of the VENTANA PD-L1 (SP263) Assay in non-small cell lung cancer (NSCLC). ....

United States , Jo Lynn Garing , Roche Tecentriq , Roche Diagnostics Communications , World Health Organization , European Commission , Roche Group , Head Of Pathology Lab At Roche Diagnostics , Jill German , Pathology Lab , Dow Jones Sustainability Indices , Chugai Pharmaceutical , Health Organization , Lung Cancer , Roche Diagnostics , Lynn Garing ,